Kodiak Sciences Inc
Clinical trials sponsored by Kodiak Sciences Inc, explained in plain language.
-
New eye injection aims to control dangerous swelling
Disease control Recruiting nowThis study is testing if a new eye injection called tabirafusp alfa (KSI-101) can safely reduce swelling in the retina caused by inflammation. It will involve about 150 people with this specific type of eye swelling and compare the real injection to a sham (pretend) procedure. Th…
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New eye injection aims to halt vision loss from inflammation
Disease control Recruiting nowThis study is testing if an experimental drug called KSI-101, injected into the eye, can safely reduce swelling and improve vision in people with macular edema caused by inflammation. It will compare the drug against a sham (pretend) injection in 150 participants. The main goal i…
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC